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Introduction
Chimeric antigen receptor (CAR) T cell
therapy has been shown to be highly
effective against leukemia and lymphoma.
However, its efficacy in treating solid tumors
has been limited due to several factors that
include tumor antigen heterogeneity,
immunosuppressive microenvironments, and
nutritional constraints. Therefore,
development of effective cellular therapies
for solid tumors requires adjuvants that can
help T cells overcome these intrinsic
barriers. Rapid determination of these
factors requires high-throughput screening of
combinatorial libraries of cytokines and
checkpoint inhibitors in a representative in
vitro setting that can accurately predict CAR
T cell function in solid tumors. Spheroids
are three-dimensional (3D) cell cultures that
can effectively mimic solid tumor
microenvironments. To this end, we have
utilized a rapid 3D bioprinting method to
produce a large array of spheroids in 384-
well plates to rapidly identify optimal
conditions that maximize CAR T cell
infiltration and cytotoxicity in a 3D setting.
Results
• Spheroids created by magnetic bioprinting
method were highly consistent in density
and size, averaging about 525 µm in
diameter.
• Clear infiltration of the glioma spheroids by
CAR T cells was revealed and quantified
over time in the blue channel (405 nm)
within ROIs drawn around the perimeter of
the spheroids.
• Correlative glioma cell death was
measured within the same ROIs in the
green fluorescence channel (525 nm).
• U87 cells express markers of
immunosuppression indicating that the
assay can be utilized to evaluate the effect
of checkpoint inhibitors on T cell infiltration
and cytotoxicity.
Conclusions
• The use of a fluorescent microscope for
image acquisition in the assay provides an
object quantification of T cell infiltration
and anti-tumor response at microscopic
and macroscopic levels in a 3D
environment that mimics solid tumors.
• This assay can be scaled up in a 384-well
format to provide a high-throughput
platform to evaluate combinatorial libraries
of therapeutic agents that optimize CAR T
cell infiltration and cytotoxicity.
• The degree of T cell infiltration can be
further stratified by creating intra-tumoral
zones to assess depth of infiltration over
time.
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Figure 3. U87 cells express markers of immunosuppression. U87 cells were
analyzed by flow cytometry for cell-surface expression of CD273 (PD-L2), CD274 (PD-
L1), and CD275 (ICOS-L) using fluorescent antibodies as indicated. The cells exhibited
significant levels of immunosuppression marker expression compared to unstained
controls.
Figure 2. Time-dependent quantification of CAR T cell infiltration into U87
spheroids. A) The video was taken using fluorescence microscopy to track T cell
infiltration (Blue Hoechst stain) into a U87 cell spheroid (GFP) to quantify infiltration
over time within a region-of-interest (ROI; yellow outline) drawn around the perimeter of
the spheroid. B) Fluorescence intensity measurements over time within the ROI show
an inverse correlation between the CAR T cell infiltration and spheroid viability.
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Methods
We used magnetic 3D bioprinting to produce
a large array of spheroids composed of U87
glioma cells expressing green fluorescent
protein (GFP) in a 384-well plate. CAR T
cells, labeled with Hoechst stain for
fluorescent visualization, were added to the
spheroid cultures in the presence of
cytokines and checkpoint inhibitors to
determine optimal combinations for T cell
function. Time-lapse fluorescence
microscopy was used to visualize and
measure tumor spheroid viability (GFP
intensity) and T cell infiltration by acquiring
images over a 48-hour time period. Flow
cytometry was also used prior to the addition
of the CAR T cells and cytokines to assess
for the presence of immunosuppression



















Figure 1. Fluorescent microscopy images of select timepoints after addition of
CAR T cells to U87 spheroids. The top images depict Hoechst-stained CAR T cells
as they infiltrate the U87 cell spheroid. Response of the spheroids to cytotoxic activity
of CAR T cells is depicted by the decline in GFP fluorescence (middle row). Merged
channel images (bottom row) illustrate coincidence of infiltration and tumor response.
Each set of images is shown in sequential order at hourly intervals.
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